Premium
Elevated serotonin and reduced dopamine in subregionally divided Huntington's disease striatum
Author(s) -
Kish Stephen J.,
Shannak Kathleen,
Hornykiewicz Oleh
Publication year - 1987
Publication title -
annals of neurology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.764
H-Index - 296
eISSN - 1531-8249
pISSN - 0364-5134
DOI - 10.1002/ana.410220318
Subject(s) - huntington's disease , dopamine , striatum , serotonin , neuroscience , medicine , psychiatry , psychology , disease , endocrinology , receptor
We measured the rostrocaudal distribution of serotonin, dopamine, and their metabolites in Huntington's disease striatum (caudate and putamen). Mean levels of serotonin or 5‐hydroxyindoleacetic acid were elevated in most striatal subdivisions, whereas concentrations of dopamine or its metabolite homovanillic acid were slightly to markedly reduced. Dopamine and serotonin were at control levels in the nucleus accumbens and substantia nigra. Whereas the above‐normal serotonin can most likely be accounted for by striatal atrophy, the reduced dopamine suggests either a marked down regulation of nigrostriatal dopamine neurons or an actual reduction in the arborization of the striatal dopamine neurons. As experimental animal data suggest, the relative excess of striatal serotonin or one of its metabolites may facilitate the neurodegenerative process in Huntington's disease striatum.